Collaboration Offers Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet
Summary
nuBeam is the world’s safest and most powerful accelerator-based neutron source designed specifically for the hospital environment. With this agreement, H.U.B will become the third clinical center in the world to implement NTs ground-breaking technology, enabling new therapeutic options for cancer patients. It has the potential to revolutionize radiation oncology, having demonstrated compelling success in some of the most difficult-to-treat cancers and in treating patients for whom all other treatment options have been exhausted. “We are thrilled to enter into this partnership with H.U.B and the IJB team to place the nuBeam system at one of the premier research hospitals in Europe, where together we can drive the adoption of BNCT as a powerful new modality for cancer patients,” commented Elizabeth Reczek, CEO of NT. “Our close partnership with Cosylab has enabled rapid progress towards this goal and positions Neutron Therapeutics as a leader in the field, allowing us to maximize the potential of BNCT and its beneficial impact on patients."